medicina43巻7号

2006年07月発行

今月の主題 血液腫瘍はどこまで治し得るのか 血液腫瘍の診断法

細胞免疫学的診断

著者： 鈴木律朗¹

所属機関： ¹名古屋大学医学部造血細胞移植情報管理学

ページ範囲：P.1082 - P.1089

ポイント

表面マーカーなどの細胞免疫学的診断は，時に形態学以上の知見をもたらす．

しかしながら例外は常に存在する．

このため，形態学的所見の収拾を怠ってはならない．あくまで補助的に用いるべきである．

参考文献

１) Jennings CD, Foon KA：Recent advances in flow cytometry；Application to the diagnosis of hematologic malignancy. Blood 90：2863-2892, 1997

２) Jaffe ES, et al：Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues；World Health Organization Classification of Tumours. IARC Pres, Lyon, 2001

３) Bennett JM, et al：Proposals for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol 78：325-329, 1991

４) Bene MC, et al：Proposals for the immunological classification of acute leukemias. Leukemia 9：1783-1786, 1995

５) Neame PB, et al：Classifying acute leukemia by immunophenotyping；A combined FAB-immunologic classification of AML. Blood 68：1355-1362, 1986

６) Seymour JF, et al：Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule(CD56). Leukemia 8：823-826, 1994

７) Ferrara F, et al：CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol 18：1295, 2000

phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0. Int J Hematol 77：482-489, 2003

９) Foon KA, Todd III RF：Immunologic classification of leukemia and lymphoma. Blood 68：1-31, 1986

10) Pui CH, Evans WE：Acute lymphoblastic leukemia. N Engl J Med 339：605-615, 1998

11) Yatabe Y, et al：Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma (MCL)；A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 95：2253-2261, 2000

12) Damle RN, et al：Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94：1840-1847, 1999

13) Bennett JM, et al：Proposal for the classification of chronic(mature)B and T lymphoid leukemia. J Clin Pathol 42：567-594, 1989

14) Matutes E, et al：Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78：3269-3274, 1991

15) Yamaguchi M, et al：De novo CD5-positive diffuse large B-cell lymphoma；A clinicopathologic study of 109 patients. Blood 99：815-821, 2002

16) Karnan S, et al：Analysis of chromosomal imbalances in de novo CD5-positive diffuse large B-cell lymphoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 39：77-81, 2004

17) Ogawa S, et al：CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survival. Br J Haematol 125：180-186, 2004

18) Suzuki R, et al：Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null cell phenotype. Blood 96：2993-3000, 2000

anaplastic large cell lymphoma；A review of its histopathologic, genetic, and clinical features. Blood 96：3681-3895, 2000

20) Asano N, et al：Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 29：1284-1293, 2005

21) Suzuki R：Leukemia and lymphoma of natural killer cells. J Clin Exp Hematopathol 45：51-70, 2005

22) Suzuki R, et al：Aggressive natural killer(NK)-cell leukemia revisited；Large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18：763-770, 2004

23) Suzuki R, et al：Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor)；Prognostication and categorization according to anatomic sites of involvement. Cancer 104：1022-1031, 2005